| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 5.3714 | 47 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 5.55736 | 50 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 5.68323 | 53 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 5.08889 | 41 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 5.27637 | 45 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 4.77585 | 37 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 5.04116 | 41 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 5.0302 | 40 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 5.65796 | 52 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 5.436 | 49 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 5.23526 | 46 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 6.5912 | 66 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 4.86424 | 38 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 4.48964 | 30 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 5.0107 | 41 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 5.30364 | 47 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 5.36682 | 48 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 4.98948 | 40 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 5.0383 | 41 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 5.04385 | 39 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 5.34926 | 47 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 5.51066 | 50 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 5.1863 | 45 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 5.61369 | 52 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 5.15276 | 43 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 4.82301 | 38 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 5.68154 | 53 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 5.08279 | 42 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 5.75678 | 54 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 4.92818 | 38 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 4.71134 | 34 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 5.28352 | 46 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 5.17789 | 42 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 5.02512 | 41 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 4.6892 | 34 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 4.7551 | 36 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 4.6225 | 31 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 5.70061 | 53 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 5.06727 | 41 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 7.40712 | 74 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 5.65808 | 53 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 4.67331 | 33 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 4.75546 | 35 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 4.84057 | 38 |